BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
67 results:

  • 1. Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment.
    Shaopeng Z; Yang Z; Yuan F; Chen H; Zhengjun Q
    Cancer Med; 2024 Jan; 13(2):e6959. PubMed ID: 38349050
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of CERS5 as a molecular biomarker in pan-cancer through multiple omics integrative analysis.
    Wang S; Yang J; Huang W; Yu Z; Mao Y; Feng Y; Chen J
    Cell Signal; 2024 Apr; 116():111054. PubMed ID: 38244710
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer.
    Shen K; Chen B; Yang L; Gao W
    Aging (Albany NY); 2023 Oct; 15(21):11940-11969. PubMed ID: 37905960
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential.
    Cao F; Liu Y; Cheng Y; Wang Y; He Y; Xu Y
    Sci Rep; 2023 Oct; 13(1):18265. PubMed ID: 37880233
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic significances of PD-L1- and ctla-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
    Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
    Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CircRNA circSLIT2 is a novel diagnostic and prognostic biomarker for gastric cancer.
    Wang L; Xiao S; Zheng Y; Gao Z
    Wien Klin Wochenschr; 2023 Sep; 135(17-18):472-477. PubMed ID: 37074418
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Definition of a Novel Immunogenic Cell Death-Relevant Gene Signature Associated with Immune Landscape in gastric cancer.
    Meng Y; Jin Z; Wang M; Chen D; Zhu M; Huang Y; Xia S; Xiong Z
    Biochem Genet; 2023 Oct; 61(5):2092-2115. PubMed ID: 36943521
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Endoscopic ultrasound guided diagnosis of a retroperitoneal extra-gastrointestinal stromal tumor.
    Moreta Rodríguez M; Martínez Ortega A; Maroto-Martín C; de la Serna Higuera C; Ponce Balaguer C; Fuentes-Valenzuela E
    Rev Esp Enferm Dig; 2023 May; 115(5):282-283. PubMed ID: 36719334
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outcomes of bariatric surgery in patients with inflammatory bowel disease from a French nationwide database.
    Corbière L; Scanff A; Desfourneaux V; Merdrignac A; Ingels A; Thibault R; Bouguen G; Bergeat D
    Br J Surg; 2023 Jan; 110(2):251-259. PubMed ID: 36448229
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effects of oral immunonutrition on histological changes of inflammatory infiltration of the tumor microenvironment among patients with a new diagnosis of gastric cancer.
    Molfino A; Mari A; Paldino A; Carletti R; Imbimbo G; Cardi M; di Gioia CRT; Laviano A
    Nutrition; 2023 Jan; 105():111855. PubMed ID: 36308915
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Common Variable Immunodeficiency-Associated cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors.
    Bruns L; Panagiota V; von Hardenberg S; Schmidt G; Adriawan IR; Sogka E; Hirsch S; Ahrenstorf G; Witte T; Schmidt RE; Atschekzei F; Sogkas G
    Front Immunol; 2022; 13():742530. PubMed ID: 35250968
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma.
    Wei H; Wu F; Mao Y; Zhang Y; Leng G; Wang J; Zhang W; Wang T
    Jpn J Clin Oncol; 2022 Apr; 52(4):331-345. PubMed ID: 35106596
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic polymorphisms and risk of MALT lymphoma in Greek population.
    Velissari A; Vassilakopoulos TP; Angelopoulou MK; Korkolopoulou P; Bamias G; Daikos G; Konstantopoulos K; Siakantaris M
    Curr Res Transl Med; 2022 May; 70(2):103330. PubMed ID: 34979486
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls.
    Kővári B; Pai RK
    Adv Anat Pathol; 2022 Jan; 29(1):2-14. PubMed ID: 34310370
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oncogene mutational analysis in imatinib naive population of gastrointestinal stromal tumor patients.
    Ali Abuderman AW; M Aldakheel F
    Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):26-32. PubMed ID: 34174973
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis.
    Panneerselvam K; Amin RN; Wei D; Tan D; Lum PJ; Zhang HC; Richards DM; Altan M; Grivas P; Thompson JA; Thomas AS; Wang Y
    J Natl Compr Canc Netw; 2021 Jun; 19(8):896-904. PubMed ID: 34102607
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: ctla-4 deficiency successfully treated with Abatacept.
    Angelino G; Cifaldi C; Zangari P; Di Cesare S; Di Matteo G; Chiriaco M; Francalanci P; Faraci S; Rea F; Romeo EF; Amodio D; Ursu GM; Bertocchini A; Accinni A; Crocoli A; Inserra A; Cozza R; Romano C; Licciardello M; Rinelli M; Dall'Oglio L; Cancrini C; De Angelis P; Finocchi A
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1051-e1056. PubMed ID: 34034269
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for gastrointestinal cancer immunotherapy.
    Zhang H; Li M; Kaboli PJ; Ji H; Du F; Wu X; Zhao Y; Shen J; Wan L; Yi T; Wen Q; Li X; Cho CH; Li J; Xiao Z
    Int J Biol Markers; 2021 Jun; 36(2):22-32. PubMed ID: 33788641
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre.
    Gonzalez-Mazón I; Sánchez-Bilbao L; Martín-Varillas JL; García-Castaño A; Delgado-Ruiz M; Bernat Piña I; Hernández JL; Castañeda S; Llorca J; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2021; 39(3):612-620. PubMed ID: 32896258
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Progress and challenges in gastroesophageal cancer.
    Serra O; Smyth EC; Lordick F
    Curr Probl Cancer; 2020 Dec; 44(6):100590. PubMed ID: 32451067
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.